Protein Expression Market: North America to Dominate the Market by 2023

1
Protein Expression Market to Reach 3 billion by
2023
2
Protein Expression Market
The protein expression market is expected to grow
at a CAGR of 11.7 during 2017 - 2023, according
to new market research report published by PS
Market Research. Browse Report Summary with
Detailed TOC on Protein Expression Market by
System (Prokaryotic Expression Systems, Mammalian
Cell Expression Systems, Insect Cell Expression
Systems, Yeast Expression Systems, Cell-Free
Expression Systems, Algal-Based Expression
Systems), by Product Services (Reagents,
Expression Vectors, Competent Cells, Services,
Instruments), by Application (Therapeutic,
Industrial, Research), by End User
(Pharmaceutical and Biotechnology Companies,
Academic Research Institutes, Contract Research
Organizations), by Geography (US, Canada, UK,
Germany, France, Italy, Spain, China, India,
Japan, Brazil, Mexico, South Africa) - Global
Market Size, Share, Development, Growth and
Demand Forecast, 2013-2023 at
https//www.psmarketresearch.com/market-analysis/p
rotein-expression-market
3
Protein Expression Market
Global protein expression market was worth
1,400.4 million in 2016
According to the study, the global protein
expression market is likely to grow from 1.4
billion in 2016 to 3.0 billion by 2023. Major
key players in the market are developing products
with technically advanced features that are
designed to produce high protein yield,
maintaining a balance of speed and scalability,
thereby enhancing its application in the drug
development workflow. Some of the recent advanced
product launched by the major players in the
market include Gibco ExpiCHO expression system,
launched in 2015 by ThermFisher Scientific Inc.,
that offers an increase yield of over 100-fold,
thereby enabling upto 3g/L of protein yield in
comparison to its previous CHO system. Therefore,
technically advanced products are a major factor
driving the growth of the market during the
forecast period.
4
Protein Expression Market
Insights on market segments
As per the findings of the research, prokaryotic
expression system occupied the largest share of
the protein expression market in 2016, due to the
high use of prokaryotic protein expression
systems, since they are cheaper as compared to
other expression systems. Based on products and
services, reagents are expected to hold the
largest share of the protein expression market
during the forecast period, mainly attributable
to increasing protein expression research
activities and the large-scale production of
antibodies and vaccines. Based on application,
therapeutics held the largest share of the market
in 2016, owing to the increasing prevalence of
chronic diseases such as cancer and diabetes
around the world, and high efficacy of protein
therapeutics. Pharmaceutical biotechnology
companies were the largest end user of the
protein expression products in 2016, mainly due
to the technological advancement in protein
expression research and rising production of
recombinant therapeutic proteins for disease
treatment.
5
Protein Expression Market
North America stands as the largest protein
expression market
Geographically, North America has been the
largest market for protein expression, with the
U.S. being the larger contributor to the regional
market, as compared to Canada. The dominant
position of the North American market is mainly
attributable to the rise in RD infrastructure,
increased aging population, rise in healthcare
expenditure and increasing prevalence of chronic
diseases in the region. Europe is the second
largest market for protein expression, after
North America. The Germany has been the largest
contributor to the European protein expression
market, followed by the U.K. and France. The
growth of the European market is mainly
attributable to the growing aging population,
increase in infections, rising incidences of
cardiovascular diseases, chronic pain, and
neurological disorders and RD infrastructure.
The protein expression market is expected to
witness the fastest growth in Asia-Pacific during
forecast period. Rising prevalence of diseases
such as cardiovascular disease and diabetes,
increasing RD spending, growing aging population
and increasing per capita income are some of the
driving factors boosting the Asia-Pacific market.
6
Protein Expression Market
Mergers and acquisitions a key trend in the
market
Increasing number of acquisitions is a key trend
observed in the protein expression market. The
key players globally are acquiring segments
and/or companies to increase their share in the
global market. In January 2017, Bio-Rad
Laboratories, Inc. (Bio-Rad) acquired RainDance
Technologies, Inc. (RainDance). As per the terms
of acquisition, RainDance Technologies, Inc.
offered its droplet-based solutions to Bio-Rad
Laboratories, Inc. and has extended its reach
into next generation sequencing applications.
Similarly, Takara Bio USA Holdings, Inc.
(TBUSH) acquired Rubicon Genomics, Inc.
(Rubicon) in January 2017, the acquisition was
aimed at expanding the product portfolio in next
generation sequencing sample preparation. TBUSH
also completed its acquisition of WaferGen
Bio-systems, Inc. (WaferGen) in March 2017.
7
Protein Expression Market
Key players in the market are launching new
products to offer advanced protein expression
products
Key players are launching new products in the
market to offer advanced protein expression
products. In August 2017, Thermo Fisher
Scientific Inc. launched Thermo Scientific Krios
G3i which is designed to deliver innovative
enhancements necessary for rapid adoption of
cryo-EM. The Thermo Scientific Krios G3i can be
used independently or together in a single
particle analysis workflow to make structural
analysis of the proteins, protein complexes and
other biomolecular structures faster, easier and
more accessible. In July 2017, Agilent
Technologies Inc. expanded its portfolio of
instruments for molecular diagnostics with the
introduction of the AriaDx Real-Time PCR System.
Real-time polymerase chain reaction (PCR) is
routinely used in laboratories to help identify
pathogens, genotype infectious agents, and for
cancer diagnostics. The open platform of AriaDx
makes it compatible to existing fast
chemistry-based assays that are DNA binding and
probe-based. This feature enables assay
developers and partners with optimized reaction
chemistries to quickly validate their assays on
the AriaDx. Some of the other key players
operating in this industry include Merck KGaA,
Genscript Biotech Corporation, Agilent
Technologies, Inc., Promega Corporation, Bio-Rad
Laboratories, Inc., Qiagen N.V., New England
Biolabs Inc., and Lonza Group Ltd.
8
Protein Expression Market
Download report sample at
https//www.psmarketresearch.com/market-analysis/p
rotein-expression-market/report-sample
9
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886